display:none
Skip to main content

DiMe Glossary


Drug Development Tool (DDT) Qualification Program

An FDA program that manages the Drug Development Tool (DDT) qualification process under section 507 of the Federal Food, Drug, and Cosmetic (FD&C) Act. It guides stakeholders in the development and refinement of DDTs (e.g., biomarkers, clinical outcome assessments) determined to aid drug development and regulatory review.


Want to learn more terms?

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today